Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Grade”

3,994 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,994 results

Testing effectiveness (Phase 2)UnknownNCT00005959
What this trial is testing

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Amgen
Not applicableStudy completedNCT00458562
What this trial is testing

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

Who this might be right for
Cervical CancerPrecancerous Condition
University of Washington 1,680
Not applicableEnded earlyNCT02341118
What this trial is testing

Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.

Who this might be right for
Ovarian Cancer
University Health Network, Toronto 109
Testing effectiveness (Phase 2)Looking for participantsNCT07340723
What this trial is testing

Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )

Who this might be right for
GVHD,AcuteStem Cell Transplant Complications
Daihong Liu 168
Testing effectiveness (Phase 2)Ended earlyNCT05316688
What this trial is testing

A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery

Who this might be right for
Oral Cavity Squamous Cell CarcinomaStage I Lip and Oral Cavity Cancer AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8+2 more
University of Washington 8
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Not applicableStudy completedNCT01799876
What this trial is testing

Use of Cell Therapy to Enhance Arthroscopic Knee Cartilage Surgery

Who this might be right for
Articular Cartilage Defect Grade III or IV of the Knee
Fondren Orthopedic Group L.L.P. 48
Early research (Phase 1)Study completedNCT00988559
What this trial is testing

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Who this might be right for
HPV16 PositiveCervical Intraepithelial Neoplasia (CIN 2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 132
Testing effectiveness (Phase 2)Study completedNCT00303823
What this trial is testing

Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical CancerCervical Intraepithelial Neoplasia Grade 1Human Papilloma Virus Infection
National Cancer Institute (NCI) 98
Early research (Phase 1)Study completedNCT01634503
What this trial is testing

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 9
Testing effectiveness (Phase 2)Looking for participantsNCT05023018
What this trial is testing

NEO100 and High-Grade Meningioma

Who this might be right for
Residual, Progressive or Recurrent Grade II or III Meningioma
Neonc Technologies, Inc. 30
Not applicableEnded earlyNCT03240679
What this trial is testing

Endoscopic Mucosal Resection and Cellular Matrix

Who this might be right for
Barretts Esophagus With High Grade DysplasiaBarrett Adenocarcinoma
Mayo Clinic 3
Testing effectiveness (Phase 2)Study completedNCT00404248
What this trial is testing

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Large-scale testing (Phase 3)Active Not RecruitingNCT05257408
What this trial is testing

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

Who this might be right for
Ovarian NeoplasmFallopian Tube NeoplasmsPeritoneal Neoplasms
Corcept Therapeutics 381
Testing effectiveness (Phase 2)Study completedNCT00663429
What this trial is testing

Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine Carcinoma
Callisto Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT00063986
What this trial is testing

Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group 110
Not applicableActive Not RecruitingNCT07171294
What this trial is testing

Reproducibility of Minimally Invasive Surgery for Grade III Hemorrhoids

Who this might be right for
HemorrhoidectomyMinimal Invasive Surgery
Hospital Son Llatzer 20
Early research (Phase 1)Temporarily pausedNCT05139056
What this trial is testing

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Who this might be right for
Currently Only Enrolling Glioblastoma Patients at First Recurrence
City of Hope Medical Center 36
Not applicableUnknownNCT04821102
What this trial is testing

Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration

Who this might be right for
Degenerative ArthritisKnee Arthritis
R-Bio 21
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Load More Results